Popular Sunscreen Ingredient in Europe and Asia Gets FDA Approval

Bemotrizinol is the first new sunscreen ingredient approved in the U.S. in more than 25 years

5 Questions on Cancer Survivorship

June is National Cancer Survivors Month, which aims to raise awareness for ongoing support

Using 3D Patient Models for Precision Treatment in Gynecologic Cancers

Experts at Moffitt are using dimensional tumor models to better predict treatment response and guide personalized therapy

A Father’s Strength, a Daughter’s Purpose

Watching her dad battle blood cancer inspired Brianna Pratts to pursue a career in cancer care

Moffitt Unveils New Digital Pathology Lab

Transitioning from physical slides to digital images increases diagnostic accuracy and turnaround time

Study Shows Personalized Vaccine Could Help Prevent Melanoma Recurrence

Five-year data shows the personalized treatment plus immunotherapy lowered disease relapse risk by 49%

Blood Test May Help Detect Some Cancers Earlier, Study Finds

Large trial suggests multi-cancer blood screening could reduce advanced-stage diagnoses, but key questions remain

Blood Test Added to Updated Colorectal Cancer Screening Guidelines

The Shield blood test was approved by the FDA in 2024

Weekly Virtual Symptom Check-Ins Linked to Better Quality of Life in Advanced Cancer

Trial of more than 1,200 patients shows smaller declines in well-being for those using a digital monitoring tool

Endeavor